
-
Schauffele determined to win Claret Jug back
-
Thousands of Afghans win UK asylum after huge data breach
-
Two dead in New Jersey as soaked US northeast braces for more rain
-
US banks see lower recession risk despite tariff fog
-
Springbok Wiese banned for four matches over head butt
-
Two men who chopped down iconic UK tree handed jail sentences
-
Syrian forces accused of 'executions' in Druze area as Israel launches strikes
-
EU threatens US planes and whiskey while pressing for deal
-
Prosecutor asks Brazil's Supreme Court to find Bolsonaro guilty of coup
-
US consumer inflation accelerates as tariff effects creep in
-
Stocks diverge, as US inflation puts focus on Trump's tariffs
-
West Indies cricket chief calls emergency meeting after Australia debacle
-
Fallen Austrian tycoon Benko charged with fraud
-
Rome, Navalny widow blast Italy invite for pro-Kremlin maestro
-
Las Vegas Sands makes $8 bn Singapore bet with resort expansion
-
Thousands of Afghans and families brought to UK after data breach: minister
-
US consumer inflation accelerates as tariff scrutiny grows
-
Springboks captain Kolisi makes first appearance of season
-
Man City sign kit deal worth reported £1 billion
-
UN demands justice in any Ukraine peace talks, as civilian deaths spike
-
India's cricket stars consoled by King Charles after Lord's defeat
-
Scheffler 'couldn't care less' about being British Open favourite
-
German court rejects Yemenis' claim over US strikes
-
Russia suggests Trump is emboldening Ukraine, delaying peace
-
Navalny widow blasts Italy's invite for pro-Kremlin maestro
-
Stock markets gain, dollar dips before US inflation
-
Israel strikes Syrian forces sent into Druze-majority Sweida
-
Tesla marks India entry with first showroom
-
Rahm 'confident' of ending Spain's British Open wait
-
Astronauts from US, India, Poland, Hungary on SpaceX capsule return to Earth
-
England call up Dawson to replace injured Bashir ahead of fourth Test
-
Ukraine covers frontline roads with anti-drone nets
-
Barca star Yamal faces probe into dwarf entertainers at 18th birthday
-
China's Xi vows greater support for Russia as meets Lavrov
-
England midfielder Henderson joins Brentford
-
Markets rise as China's economy meets forecasts
-
Markets mostly rise as China's economy meets forecasts
-
Syrian forces enter Druze city after deadly clashes
-
'World's oldest marathon runner' dies aged 114 in road accident
-
Indigenous Australians lose landmark climate court case against government
-
Skidding Nissan to halt production at Japanese plant
-
Passion for hand fans sizzles in burning Spanish heat
-
Drought-hit Serbian raspberry farmers fear 'catastrophic' future
-
Jadeja hailed for taking India close but Gavaskar rues lack of risk
-
'Dialogue' must be at heart of China, Australia ties, PM tells Xi
-
Ivory Coast farmers hope tech tempts jaded youth back to fields
-
France's new star Lanier ready for home pressure at badminton worlds
-
Hong Kong leader backs same-sex couples' rights bill
-
Nvidia says it will resume sales of 'H20' AI chips to China
-
Egypt grand museum delay puts tourism hopes on hold

RFK Jr ousts entire US vaccine panel over alleged conflicts
US Health Secretary Robert F. Kennedy Jr. on Monday announced he was dismissing all members of a key federal vaccine advisory panel, accusing them of conflicts of interest -- his latest salvo against the nation's immunization policies.
The removal of all 17 experts of the Advisory Committee on Immunization Practices (ACIP) was revealed in a Wall Street Journal op-ed and an official press release.
Kennedy, who has spent two decades promoting vaccine misinformation, cast the move as essential to restoring public trust, claiming the committee had been compromised by financial ties to pharmaceutical companies.
"Today we are prioritizing the restoration of public trust above any specific pro- or anti-vaccine agenda," he said in a statement from the Department of Health and Human Services.
"The public must know that unbiased science -- evaluated through a transparent process and insulated from conflicts of interest — guides the recommendations of our health agencies."
In his op-ed, Kennedy claimed the panel was "plagued with persistent conflicts of interest" and had become "little more than a rubber stamp for any vaccine."
He added that new members were being considered to replace those ousted -- all of whom were appointed under former president Joe Biden.
ACIP members are typically chosen for their recognized expertise and are required to disclose potential conflicts of interest.
The decision was met with alarm by Paul Offit, a pediatrician and leading expert on virology and immunology who served on the panel from 1998 to 2003.
"He believes that anybody who speaks well of vaccines, or recommends vaccines, must be deeply in the pocket of industry," Offit told AFP. "He's fixing a problem that doesn't exist."
Once a celebrated environmental lawyer, Kennedy pivoted from the mid-2000s to public health -- chairing a nonprofit that discouraged routine childhood immunizations and amplified false claims, including the long-debunked theory that the Measles, Mumps and Rubella (MMR) vaccine causes autism.
Since taking office, he has curtailed access to Covid-19 shots and continued to raise fears around the MMR vaccine -- even as the United States faces its worst measles outbreak in years, with three reported deaths and more than 1,100 confirmed cases.
Experts warn the true case count is likely far higher.
"How can this country have confidence that the people RFK Jr. wants on the Advisory Committee for Immunization Practices are people we can trust?" Offit asked.
He recalled that during US President Donald Trump's first term, several states formed independent vaccine advisory panels after the administration pressured federal health agencies to prematurely approve Covid-19 vaccines ahead of the 2020 election.
That kind of fragmentation, Offit warned, could happen again.
ACIP is scheduled to hold its next meeting at the headquarters of the Centers for Disease Control and Prevention in Atlanta from June 25 to June 27.
Vaccines for anthrax, Covid-19, human papillomavirus, influenza, Lyme disease, respiratory syncytial virus, and more are on the agenda.
W.Moreno--AT